Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population
- PMID: 28535894
- DOI: 10.1016/j.rbre.2016.09.016
Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population
Abstract
Introduction: Multiple sclerosis (MS) and neuromyelitis optica (NMO) are demyelinating diseases of the central nervous system. Autoimmunity in patients with demyelinating disease and in their families has been broadly investigated and discussed. Recent studies show a higher incidence of rheumatic autoimmune diseases among adult patients with MS or NMO and their families, but there are no studies in the pediatric population.
Objective: To evaluate an association of MS and NMO with autoimmune rheumatic diseases in pediatric patients.
Method: 22 patients younger than 21 years old with MS or NMO diagnosed before the age of 18 years were evaluated regarding epidemiological data, clinical presentation, association with autoimmune diseases, family history of autoimmune diseases, laboratory findings, imaging studies and presence of auto-antibodies.
Results: Among the patients studied, there was a prevalence of females (68.1%). The mean age of symptoms onset was 8 years and 9 months and the mean current age was 16 years and 4 months. Two patients (9%) had a history of associated autoimmune rheumatic disease: one case of juvenile dermatomyositis in a patient with NMO and another of systemic lupus erythematosus in a patient with MS. Three patients (13%) had a family history of autoimmunity in first-degree relatives. Antinuclear antibody was found positive in 80% of patients with NMO and 52% of patients with MS. About 15% of antinuclear antibody-positive patients were diagnosed with rheumatologic autoimmune diseases.
Conclusion: Among patients with demyelinating diseases diagnosed in childhood included in this study there was a high frequency of antinuclear antibody positivity but a lower association with rheumatologic autoimmune diseases than that observed in studies conducted in adults.
Keywords: Autoimmune diseases; Childhood; Demyelinating diseases; Doenças autoimunes; Doenças desmielinizantes; Doenças reumáticas; Infância; Rheumatic diseases.
Copyright © 2016 Elsevier Editora Ltda. All rights reserved.
Similar articles
-
The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease.Mult Scler. 2012 Jan;18(1):5-10. doi: 10.1177/1352458511431077. Epub 2011 Dec 6. Mult Scler. 2012. PMID: 22146604 Review.
-
Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.Mult Scler Relat Disord. 2017 Feb;12:39-43. doi: 10.1016/j.msard.2017.01.004. Epub 2017 Jan 6. Mult Scler Relat Disord. 2017. PMID: 28283104
-
Epidemiology of pediatric multiple sclerosis, neuromyelitis optica, and optic neuritis in Taiwan.J Neurol. 2020 Apr;267(4):925-932. doi: 10.1007/s00415-019-09647-9. Epub 2019 Nov 28. J Neurol. 2020. PMID: 31781928
-
Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.PLoS One. 2015 Jul 29;10(7):e0127757. doi: 10.1371/journal.pone.0127757. eCollection 2015. PLoS One. 2015. PMID: 26222205 Free PMC article. Clinical Trial.
-
Specificities of Children with Multiple Sclerosis and Neuromyelitis Optica.Cent Nerv Syst Agents Med Chem. 2018 Jan 26;18(1):16-20. doi: 10.2174/1871524916666151210143548. Cent Nerv Syst Agents Med Chem. 2018. PMID: 26654228 Review.
Cited by
-
Pediatric Neuromyelitis Optica Spectrum Disorders.Curr Treat Options Neurol. 2018 May 2;20(6):19. doi: 10.1007/s11940-018-0502-9. Curr Treat Options Neurol. 2018. PMID: 29721683 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical